CD8A and neoplasm: Paclitaxel or carboplatin treatment in mice with MMTV-PyMT tumors was counteracted by increased IL-10 secretion from TAMs, leading to downregulated IL-12 production in dendritic cells and the inhibition of CD8+ T-cell anti-tumor activity [128].